戻る Agenda
S28 : The Practice of Patient Preference Study and Its Value as Evidence: Connecting the Patient's Voice to Decision-Making
Session Chair(s)
Inaha Okuda
Patient Focused Development Lead, GlaxoSmithKline K.K., Japan
Speaker(s)
Yasuo Sugitani, PhD
Senior Director, Biometrics Dept., Chugai Pharmaceutical Co., Ltd., Japan
Masayuki Hamakawa
Head of Health Outcomes Research Dept, SSRI Co., Ltd., Japan
Kazuo Hasegawa
Representative Director, OnestepLung Cancer Patient Network ONE STEP, Japan
Shun Tezuka
, PMDA, Japan